Daiichi Sankyo
Mark Lindberg is a seasoned professional in business development and analytics, currently serving as Senior Director of Global Business Development, Transactions at Daiichi Sankyo US since January 2014. Mark has held multiple roles within the company, including Director and Associate Director of Global Business Development, as well as positions in finance and contract analytics. Prior to joining Daiichi Sankyo, Mark worked as Engineer 1 at Maguire Group Inc. Mark holds a Master of Engineering Management from Duke University and a Bachelor of Science in Civil Engineering from Lehigh University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.